Sexton Biotechnologies is a subsidiary of BioLife Solutions, Inc. and focuses on purpose-built tools for cell & gene therapy (CGT) manufacturing, with strengths in biopreservation media and advanced cell culture supplements. Sexton’s solutions are designed to be flexibly integrated to help accelerate, scale, and automate CGT workflows—reducing manual steps and enabling closed, process-ready manufacturing.
Key offerings include specialized CGT tools and media, as well as workflow-enabling accessories such as vial-related handling components, storage solutions, and closed-system fluid handling. For example, BioLife highlights Sexton-origin platforms such as Signata CT-5™ (closed fluid management for cell culture processes) and CellSeal® closed-system cryogenic storage tools, alongside Sexton’s human platelet lysate supplements.
■ Product Portfolio
Vicbio Biotechnology Co., Ltd. provides the full range of Sexton Biotechnologies products.
⇨ Inquire or Order immediately ⇦
● Stemulate®-CP: A heparin-free human platelet lysate manufactured under an ISO 9001:2015 certified quality management system, with regulatory support including a U.S. FDA Master File (as stated by the manufacturer). Offered in common production-friendly pack sizes and typically used as a cell culture supplement across CGT workflows.
● nLiven PR®: A cGMP-ready, pathogen-reduced human platelet lysate utilizing E-Beam irradiation (manufacturer-stated), designed to reduce lot-to-lot variability via a biodefined composition while providing high growth factor/cytokine content to support robust cell expansion. Manufacturer notes it is produced under ISO 9001:2015 and is FDA registered/inspected since 2011.
● T-Liven PR®: A GMP-ready pathogen-reduced human platelet lysate developed for closed bioprocessing and released against a validated T-cell growth promotion assay (manufacturer-stated), supporting immune cell manufacturing use cases. Manufacturer also notes E-Beam pathogen reduction, FDA Master File, and Japan PMDA Certificate of Suitability.
